HOME > BUSINESS > Article

Text Size

small

medium

large


Japan Firm Files for Patent for Envisioned COVID-19 Vaccine

Japan Firm Files for Patent for Envisioned COVID-19 Vaccine

   Tokyo, April 1 (Jiji Press)--Japanese biopharmaceutical firm AnGes Inc. <4563> said Wednesday that it and Osaka University have applied for a patent for a COVID-19 coronavirus vaccine that they are jointly developing.
   In the joint project, the firm, based in Ibaraki, Osaka Prefecture, western Japan, and the university are currently testing vaccine components on animals.

To read a full story, please click here to find out how to subscribe.

BUSINESS

Aomori Tourism Information

HEADLINES

POLITICS
Japan in 1989 Mulled Then Emperor Akihito's Visit to S. Korea: Records
ECONOMY
Tokyo Forex (5 P.M.): U.S. Dollar=107.64-67 Yen; Euro=1.0959-0961 Dollars
SPORTS
Speed Staking: Miho Takagi Joins Nippon Sport Science University's PR Section
OTHER
Existing Drug Found Effective in Curbing Alzheimer Substance Accumulation

AFP-JIJI PRESS NEWS JOURNAL


Photos